robins browne Flashcards
T/F: Pencillin V is often used instead of penicillin G because it has a wider spectrum of antibacterial activity
FALSE: V and G have same spectrum
but
V is taken orally (more acid stable)
Bactericidal antimicrobial agents are preferred to bacteriostatic ones when:
the patient’s immune system cannot be relied upon to eradicate the infection
T/F: semisynthetic penicillins were designed to be less toxic than penicillin G
FALSE:
penicillin G has little toxicity in hmans
Why are Semisynthetic penicillins preferred to pencillin G
- ease of administration - oral
2. broader antimicrobial spectrum
Alter pharmacological properties (3)
- change kinetics - distribution, toxicity, spectrum
2. extend patent and make money
Tetracyclines
4 ring Naturally occuring 4 times a day, short half life Excreted n bile Doxycycline(modified): taken 1x, 2x per day
Penicillin G
GP and GN cocci
Disadvantage: injected, dont know how much active drug is in the body
Penicillin V
Phenoxy methyl group instead of benzyl group
Oral
Ampicillin
Oral
Broader spectrum than PenV
GN rods
~amoxycillin
Methicillin
Penicillin-resistant S.aureus
Injected
Carbenecilin
Pseudomonas GN rod
Important hospital acquired pathogens
Not used -big dose intravenously
Ticarcilin used instead
Sulphonamides
Target folic acid synthesis - don’t affect humans
Cell Wall antimicrobial target
Act on peptidoglycan synthesis
Peptidoglycan = disaccharide of NAG and NAM
End glycine displaces terminal D alanine - catalysd by transpeptidases, endopeptidases, carboxylases = penicillin binding proteins
Vancomycin
Used to treat MRSA
Resistance in Enterococci if a different terminus is made because vancomycin can’t bind to sugar
VRE
When resistance to commensals transfers to other bacteria
VISA
Vancomycin Intermediate Staph Aureus
Make more peptidoglycan making it difficult for vancomycin to diffuse through
VRSA
Vancomycin resistant Staph aureus - very rare
VSSA
Vancomycin susceptible staph aureus
Suicide inhibitor
irreversible enzyme inhibition that occurs when an enzyme binds a substrate analogue and forms an irreversible complex
Transpeptidases
Bacterial enzyme that cross links peptidoglycan to form cell walls
Clavulanic Acid
Beta lactamase inhibitor
Combines with penicillin group antibiotics to overcome resistance
Beta lactamase binds to clavulanic acid’s beta lactam ring
Does not inhibit chromosomal B-lactamase (ONLY PLASMID ENCODED)
Augmentin
Clavulanic acid + amoxycilin in equal parts
Timetin
Ticarcillin and clavulanic acid
Ticarcillin
Treatment of pseudomonas
Treats GN bacteria
Ability to prevent cross-linking of peptidoglycan during cell wall synthesis
Aminoglycosides
Inhibit protein synthesis Against GN aerobes and anaerobic bacilli e.g. streptomycin, gentamicin Tobramycin: antipseudomonal Gentamycin: used with penicilli Need to be injected
Streptomycin
First cure for TB
Bactericidal
Binds to 30S subunit of ribosome -> codon misreading –> inhibition
Broad spectrum
Types of Streptomycin
Strep S: susceptible, WT
Strep R: resistant, grows in presence of high and low strep
Strep D: streptomycin corrects defect in ribosome
Antibacterial spectrum of beta-lactam antibiotics vary because:
Bacteria have different PBPs
Accessibility of antibiotic to PBPs varies
Susceptibility of antibiotic to B-lactamase varies
Mechanisms of Resistance
Inactivation: hydrolysis (b-lactams), covalent modification (aminoglycoside)
Altering target of drug action:
Modify target to less sensitive form (b-lactam), overproduce target (vancomycin)
Reduce access of drug to target:
Reduced entry into cell, increase efflux from cell (aminoglycosides)
Failure to activate inactive precursor of drug (metronidazole) - activated by bacterial metabolic enzymes
Aminoglycoside resistance
Acetylation
Modified outer membrane –> reduced entry
Efflux: drug comes into cell, cell pumps it back out
Ribosomal mutation leading to reduced binding (strD)
Metronidazole:
Treats bacterial and parasitic infections
Obligate anaerobes
Target = nitroreductase, not present in humans